Artesunate, a potential drug for treatment of Babesia infection

Youn Kyoung Goo, M. Alaa Terkawi, Honglin Jia, G. Oluga Aboge, Hideo Ooka, Bryce Nelson, Suk Kim, Fujiko Sunaga, Kazuhiko Namikawa, Ikuo Igarashi, Yoshifumi Nishikawa, Xuenan Xuan

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

The effects of artesunate, a water-soluble artemisinin derivative, against Babesia species, including Babesia bovis, Babesia gibsoni and Babesia microti were studied. Cultures of B. bovis and B. gibsoni were treated with 0.26, 2.6, 26 and 260μM artesunate, showing inhibition of parasite growth at concentrations equal to and greater than 2.6μM artesunate by days 3 post-treatment for B. gibsoni and B. bovis in a dose-dependent manner. Consistent with in vitro experiments, artesunate was effective in the treatment of mice infected with B. microti at doses equal to and greater than 10. mg/kg of body weight on days 8-10 post-infection. Taken together, these results suggest that artesunate could be a potential drug against Babesia infection.

Original languageEnglish
Pages (from-to)481-486
Number of pages6
JournalParasitology International
Volume59
Issue number3
DOIs
StatePublished - Sep 2010

Keywords

  • Artesunate
  • Babesia bovis
  • Babesia gibsoni
  • Babesia microti

Fingerprint

Dive into the research topics of 'Artesunate, a potential drug for treatment of Babesia infection'. Together they form a unique fingerprint.

Cite this